Literature DB >> 18690440

Double-faced cell-mediated immunity in beta-thalassemia major: stimulated phenotype versus suppressed activity.

Marjan Gharagozloo1, Mehran Karimi, Zahra Amirghofran.   

Abstract

In this study, the immunologic abnormalities of Iranian beta-thalassemia major patients were characterized, considering their clinical parameters including splenectomy status and iron overload. Serum samples and peripheral blood mononuclear cells were collected from 28 patients and 30 age- and sex-matched healthy individuals. Patients with thalassemia showed significantly increased absolute lymphocyte counts compared with the control group. An increased number of activated T cells and higher levels of serum neopterin were also observed in thalassemia patients, which suggest chronic stimulation of immune system. On the contrary, T-cell proliferation and interleukin 2 (IL-2), interferon gamma (IFN-gamma), and IL-4 production were suppressed in patients compared to controls. Patients with high serum ferritin levels produced significantly less IFN-gamma and IL-2, indicating the immunosuppressive effect of iron overload in beta-thalassemia patients. The serum levels of tumor necrosis factor alpha and absolute counts and percentages of B and T cells were higher in splenectomized patients; however, serum levels of neopterin significantly decreased in splenectomized patients compared to the non-splenectomized group. Taken together, T lymphocytes express activated phenotype in polytransfused beta-thalassemia major patients, while T cell proliferation and effector function are significantly suppressed. Multiple blood transfusion and continuous immune stimulation could be responsible for making such a double-faced immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690440     DOI: 10.1007/s00277-008-0564-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  11 in total

1.  Alteration of T Cell Subtypes in Beta-Thalassaemia Major: Impact of Ferritin Level.

Authors:  Batoul Pourgheysari; Leila Karimi; Pezhman Beshkar
Journal:  J Clin Diagn Res       Date:  2016-02-01

2.  Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging.

Authors:  Batoul Pourgheysari; Leila Karimi; Raihaneh Bagheri; Soleiman Kheiri
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-07       Impact factor: 0.900

3.  A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study.

Authors:  Afshan Sumera; Nur Diana Anuar; Ammu Kutty Radhakrishnan; Hishamshah Ibrahim; Nurul H Rutt; Nur Hafiza Ismail; Ti-Myen Tan; Abdul Aziz Baba
Journal:  Biomedicines       Date:  2020-04-26

4.  Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes.

Authors:  Arnone Nithichanon; Inthira Tussakhon; Waraporn Samer; Chidchamai Kewcharoenwong; Manabu Ato; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

5.  Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?

Authors:  Mehran Karimi; Vincenzo De Sanctis
Journal:  Acta Biomed       Date:  2020-05-11

6.  Iron Supplementation Interferes With Immune Therapy of Murine Mammary Carcinoma by Inhibiting Anti-Tumor T Cell Function.

Authors:  Piotr Tymoszuk; Manfred Nairz; Natascha Brigo; Verena Petzer; Simon Heeke; Brigitte Kircher; Natascha Hermann-Kleiter; Victoria Klepsch; Igor Theurl; Günter Weiss; Christa Pfeifhofer-Obermair
Journal:  Front Oncol       Date:  2020-12-04       Impact factor: 6.244

7.  Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose.

Authors:  Rita Carsetti; Chiara Agrati; Valeria Maria Pinto; Barbara Gianesin; Rita Gamberini; Monica Fortini; Susanna Barella; Rita Denotti; Silverio Perrotta; Maddalena Casale; Aurelio Maggio; Lorella Pitrolo; Eleonora Tartaglia; Eva Piano Mortari; Francesca Colavita; Vincenzo Puro; Massimo Francalancia; Valeria Marini; Marco Caminati; Filippo Mazzi; Lucia De Franceschi; Gian Luca Forni; Franco Locatelli
Journal:  Blood       Date:  2022-10-13       Impact factor: 25.476

8.  Preconditioning with hemin decreases Plasmodium chabaudi adami parasitemia and inhibits erythropoiesis in BALB/c mice.

Authors:  Esther Dalko; Véronique Gaudreault; Jaime Sanchez Dardon; Robert Moreau; Tatiana Scorza
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 9.  Ineffective erythropoiesis in β -thalassemia.

Authors:  Jean-Antoine Ribeil; Jean-Benoit Arlet; Michael Dussiot; Ivan Cruz Moura; Geneviève Courtois; Olivier Hermine
Journal:  ScientificWorldJournal       Date:  2013-03-28

Review 10.  Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015.

Authors:  Hadi Darvishi Khezri; Ebrahim Salehifar; Mehrnoush Kosaryan; Aily Aliasgharian; Hossein Jalali; Arash Hadian Amree
Journal:  Adv Pharmacol Sci       Date:  2016-02-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.